Effective Cannabis | Research & Blog
A cancer of the immune system that is marked by the presence of a type of cell called the Reed-Sternberg cell. The two major types of Hodgkin lymphoma are classical Hodgkin lymphoma and nodular lymphocyte-predominant Hodgkin lymphoma.
In 2002, Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease. Using adult mice. Background: In the current study, they demonstrated that THC and other cannabinoids can induce apoptosis in murine and human leukemia and lymphoma cell lines as well as primary ALL cells. Responded to CB2 not CB1. You can read .. Read More
In 2008, In vivo treatment with therapies using cannabinoid receptors caused a significant reduction of tumor size in mice. Background: This study, evaluated the expression of cannabinoid receptors CB1 and CB2 in non‐Hodgkin lymphomas. You can read the full article here =>http://www.ncbi.nlm.nih.gov/pubmed/18546271
In 2017, Herb provided a guide to understanding cannabis and cancer treatment. Background: Here’s a guide to give an understanding of cannabis and cancer treatment. Covering the Top 10 cancers – Brain cancer, Breast cancer, Colon cancer, Hodgkin’s Lymphoma, Leukemia, Liver cancer, Lung cancer, Prostate cancer, Stomach cancer & Skin cancer. You can read the full article here => https://herb.co/marijuana/news/cannabis-cancer-treatment
In 2013, Expression and Functional Relevance of Cannabinoid Receptor 1 in Hodgkin Lymphoma. BACKGROUND: Examined the distribution of CB1 protein in primary cases of HL. Using lymphoma derived cell lines. You can read the full article here => https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3857220/
